ARTICLE | Company News
Genta, Relgen LLC deal
April 24, 2000 7:00 AM UTC
GNTA will acquire Relgen's rights and assets related to a portfolio of gallium-containing compounds used to treat disorders associated with accelerated loss of bone calcium. Relgen obtained rights to ...